Opportunities in The (Overpriced) Japan Pharma Sector
As a defensive sector, Japan’s pharmaceutical sector has had an up-and-down time of it during the Abe era. In the early days of Abenomics, the...
140 Views
This Week in Blockchain & Cryptos: Blockchain for Football 🏆⚽ Talent Management & Piracy Prevention
From missed penalties to a shocking German exit this week, this has been by far the most action-packed World Cup we have had in a long time. Such...
226 Views
Eisai FY17 Earnings - First Glance
Eisai Co Ltd (4523 JP) reported FY17 results on May 15, 2018 Lenvima sales ramp-up + Upfront payment from Merck led FY17 topline growth and gross...
94 Views
Ono’s Stock Price Decline on Merck’s KN-189 Success
On April 16, 2018, the topline data for Ono Pharmaceutical Co Ltd (4528 JP) Opdivo and Merck & Co. Inc. (MRK US) Keytruda, both as a...
125 Views
Will Actinogen Ace Alzheimer's?
Alzheimer’s disease is an incurable neurodegenerative disorder that robs the affected individuals of memory, self-care and quality of life,...
215 Views